key: cord-0778830-s94ygfua authors: Pasomsub, Ekawat; Watcharananan, Siriorn P.; Watthanachockchai, Treewat; Rakmanee, Kingkan; Tassaneetrithep, Boonrat; Kiertiburanakul, Sasisopin; Phuphuakrat, Angsana title: Saliva sample pooling for the detection of SARS‐CoV‐2 date: 2020-08-25 journal: J Med Virol DOI: 10.1002/jmv.26460 sha: 82627c73cfc05102b7cc7beee8e98a982709736b doc_id: 778830 cord_uid: s94ygfua As the battle against coronavirus disease 2019 pandemic continues, an increase in workload and medical expenses have been a concern to the health care system worldwide. Developing a measure that helps to conserve the health care resource is, therefore, highly desirable, and the pooling of the specimens for testing is one of the attractive strategies. Recently we showed that saliva could be a potential alternative specimen for the detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by real‐time polymerase chain reaction (RT‐PCR). In the present study, we performed the pooling of saliva specimens for testing by SARS‐CoV‐2 RT‐PCR. We showed that the saliva pool of either five or ten samples, by allowing the detection of either gene in the pool at an increased cycle threshold cut‐off value, further performing individual sample testing in the positive pools did not compromise the detection of SARS‐CoV‐2. This article is protected by copyright. All rights reserved. The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical specimens is one of the crucial steps of coronavirus disease 2019 (COVID-19) diagnosis and control. Real-time polymerase chain reaction (RT-PCR) is Accepted Article an important and widely used diagnostic tool for the detection of SARS-CoV-2. For the detection of SARS-CoV-2, the preferred specimen from the upper respiratory tract includes nasopharyngeal, mid-turbinate, or nasal swab. 1 However, the drawback of the test is the nature of the relatively invasive procedure, the need for trained personnel, swab, and personal protective equipment (PPE). Williams and coworkers, as well as our group recently showed that saliva might be an alternative specimen for the diagnosis of COVID-19 in ambulatory patient settings. 2, 3 The advantages of saliva as a clinical specimen include the ease and non-invasive nature of the specimen collection, and the reduced use of the swabs and PPE. However, during the outbreak or pandemic, availability of resources, including reagents and laboratory capacity, might be in short of supply. 4 Sample pooling for RT-PCR has been used to detect various infections, including human immunodeficiency virus, and hepatitis B and C viruses. 5, 6 Specimen pooling for the detection of SARS-CoV-2 using nasopharyngeal swab specimens was demonstrated to reduce the resources and laboratory workload in low prevalence areas. 7 However, sample pooling might decrease the sensitivity of viral detection due to specimen dilution and the influence of storage time and conditions. In this study, we investigated the potential of pooling saliva specimens for the detection of SARS-CoV-2. The storage RNA specimens extracted from saliva samples of patients under investigation for COVID-19 during the outbreak in Bangkok, Thailand, in the This article is protected by copyright. All rights reserved. previous study 2 were retrieved. Ten μL of the extracted RNA from each patient was pooled consecutively into pools of five samples and pools of ten samples. Twenty μL of RNA from each pool was used to perform RT-PCR. RT-PCR of the pools was carried out using a SARS-CoV-2 Nucleic Acid Diagnostic Kit (Sansure, Changsha, China), which targets the ORF1ab and N gene fragments as previously described. The kit also targets RNase P gene as a control. The pools that detected either of ORF1ab and N gene fragments before 45 cycles were retested for the detection of SARS-CoV-2 individually. The study protocol was reviewed and approved by the Human Research Ethics Committee, Faculty of Medicine Ramathibodi Hospital, Mahidol University. Wilcoxon signed-rank test was used to compare the cycle threshold (Ct) value in the pool samples and individual samples. The negative RT-PCR of the target gene was set at the Ct value of 45.01 for the statistical analysis. A one-tailed p <0.05 was considered statistically significant. All statistical analyses were performed using GraphPad Prism version 8 (GraphPad Software, San Diego, CA, USA). Two hundred RNA specimens extracted from saliva samples were pooled consecutively into the pools of five samples and the pools of ten samples given a total of 40 pools of five samples and 20 pools of ten samples. Of the 40 pools of five samples, there were 27 negative pools. Eleven pools detected of both ORF1ab and N genes, and two pools detected only N gene (Table 1 ). This article is protected by copyright. All rights reserved. (Table S1 ). Of the 20 pools of ten samples, there were seven negative pools. Twelve pools detected both ORF1ab and N genes, and one pool detected only the ORF1ab gene (Table 1) . Of the total, ten pools contained one positive sample, two pools contained two positive samples, and one pool contained three positive samples. The comparison of the Ct values between the positive pools and the individual specimens was performed ( Figure 2 ). In the pools that contained one positive specimen, the median Ct values of the ORF1ab gene in the pools of ten was 36.7 (33.7-39.1), which was significantly higher than that of the individual specimens (p=0.001). The median Ct value of the N gene in the pools of ten was 34.7 (32.1-38.9), which not significantly Accepted Article different from that of the individual specimens (p=0.461). Ct values of both ORF1ab and N genes of the pools that contained two or three positive specimens were lower than those of the individual specimens (Table S1 ). All Ct values of ORF1ab and N genes in this study were compared with the Ct of immediate RT-PCR testing for SARS-CoV-2 performed in the previous study. 2 This study demonstrated the feasibility of saliva pooling as a method for the detection of SARS-CoV-2 in symptomatic patients under investigation in a low prevalence setting. We showed that saliva pools of either five or ten samples did not compromise the detection of SARS-CoV-2 if an increased Ct cut-off value and the detection of either gene from the pool were allowed for further individual specimen tests. This article is protected by copyright. All rights reserved. The detection of SARS-CoV-2 from a saliva sample is convenient. The previous studies showed that saliva might be an alternative type of specimen for the detection of SARS-CoV-2 in symptomatic patients in an acute respiratory infection clinic setting. 2, 3 The pooling of saliva specimens is an appealing method for conserving testing resources in a low prevalence area. The feasibility of the pooling of nasopharyngeal swab specimens for the detection of the virus has been shown recently. 8 Although either the saliva pool of five or ten samples could detect SARS-CoV-2 in the specimens, pool size should be selected according to the disease prevalence to save the test, and hence the cost, for each negative pool. 7, 11 In our setting, the prevalence of the disease was 9.0%. The total test numbers performed in this study were 105 and 150 in the pool of five samples and the pool of ten samples, respectively. Therefore, the pool of five samples was more appropriate than the pool of ten samples to decrease the resource burden in our setting. This study described a proof-of-concept of saliva pooling for the diagnosis of COVID-19, to conserve the available resource. This article is protected by copyright. All rights reserved. We demonstrated that the storage condition, storage time, and freeze-thaw affected the detection of the virus, which was consistent with the recent study. 12 This presented an important implication that the nucleic acid testing of SARS-CoV-2 should be performed as soon as possible after specimen collection. However, in resource-limited settings, facilities and testing capacity might not be available in those areas. Our study showed one sample that was misclassified as negative after storage and freeze-thaw. False-negative results are of concern because infected persons might not be isolated and can infect others. 13 However, the recent study showed that respiratory samples from patients with at least eight days of symptoms and a SARS-CoV-2 E gene RT-PCR at the Ct value of ≥24 might predict lack of infectivity. 14 For the specimen that was initially positive but became negative in the individual test after the storage and freeze-thaw in our study, the specimen collection in this patient was performed at day 15 after the onset of symptoms, and the nasopharyngeal and throat swab of this patient was negative at the simultaneous collection. The Ct values of SARS-CoV-2 detection in saliva was found in all severe COVID-19 patients. 15 Our previous study showed that the sensitivity of SARS-CoV-2 detection in saliva was 84.2% comparing to nasopharyngeal and throat swab in ambulatory patients under investigation. 2 However, a recent study demonstrated viral detection in 64% of This article is protected by copyright. All rights reserved. asymptomatic SARS-CoV-2 infected cases from saliva specimens. 16 Of note, viral loads in saliva were lower than nasopharyngeal and throat swab. Therefore, the detection of the virus in saliva probably affected by the severity of the disease. Another limitation of the pooling strategy included the inability to evaluate the adequacy of each specimen in a pool due to the loss of ability to detect the housekeeping gene from each sample. However, with the ease of saliva collection, the saliva pooling might be an appealing method for mass-screening program or sentinel surveillance, especially in resource-limited settings. The strength of this study included the nature of our study that performed consecutive pools of the saliva samples. This study design simulated the real-life situation, which included different numbers of positive samples in the pools. We accepted the limitation that the sensitivity of the virus detection by saliva sample pooling in this study might be compromised due to RNA degradation during the storage and freeze-thaw. Also, we used the leftover extracted viral RNA instead of the saliva sample for the pooling. Cycle threshold values of ORF1ab (A-C) and N genes (D-F) in the SARS-CoV-2 detectable pools of ten and individual samples. A and D, B and E, and C and F show the pools that contained one, two, and three positive samples, respectively. Cycle threshold values of ORF1ab (A) and N genes (B) in the SARS-CoV-2 positive samples comparing immediate testing and testing after the storage. Table Table 1 Summary of the SARS-CoV-2 gene detection by specimen pooling. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 Saliva sample as a noninvasive specimen for the diagnosis of coronavirus disease 2019: a crosssectional study Saliva as a noninvasive specimen for detection of SARS-CoV-2 Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19 Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets Pool size selection when testing for SARS-CoV-2 Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications Predicting infectious SARS-CoV-2 from diagnostic samples Saliva is a reliable tool to detect SARS-CoV-2 The natural history and transmission potential of asymptomatic SARS-CoV-2 infection This study was supported by a grant from the Faculty of Medicine Ramathibodi Hospital, Mahidol University. We would like to thank physicians and nurses at the acute respiratory infection clinic at Ramathibodi Hospital and Worramin Suksuwan for their help in collecting the samples. The authors declare that there are no conflict of interests. EP and AP designed the study. TW and KR performed the experiment. AP analyzed the data. BT and AP wrote the manuscript. EP, SPW, and SK edited the manuscript. The data that supports the findings of this study are available in the supplementary material of this article.